Aliases & Classifications for Prostate Adenocarcinoma

About this section

Prostate Adenocarcinoma, Aliases & Descriptions:

Name: Prostate Adenocarcinoma 9
 
Adenocarcinoma of Prostate 60


External Ids:

Disease Ontology9 DOID:2526
SNOMED-CT55 399490008
NCIt38 C2919

Summaries for Prostate Adenocarcinoma

About this section


Disease Ontology:9 A prostate carcinoma that derives from epithelial cells of glandular origin.

MalaCards based summary: Prostate Adenocarcinoma, also known as adenocarcinoma of prostate, is related to adenocarcinoma and prostate cancer. An important gene associated with Prostate Adenocarcinoma is MSMB (microseminoprotein, beta-), and among its related pathways are Arachidonic acid metabolism and Eicosanoid Synthesis. The compounds 15(S)-HPETE and 13-L-Hydroperoxylinoleic acid have been mentioned in the context of this disorder. Affiliated tissues include prostate, bone and lymph node.

Related Diseases for Prostate Adenocarcinoma

About this section

Graphical network of the top 20 diseases related to Prostate Adenocarcinoma:



Diseases related to prostate adenocarcinoma

Symptoms for Prostate Adenocarcinoma

About this section

Drugs & Therapeutics for Prostate Adenocarcinoma

About this section

Drug clinical trials:

Search ClinicalTrials for Prostate Adenocarcinoma

Search NIH Clinical Center for Prostate Adenocarcinoma

Genetic Tests for Prostate Adenocarcinoma

About this section

Anatomical Context for Prostate Adenocarcinoma

About this section

MalaCards organs/tissues related to Prostate Adenocarcinoma:

31
Prostate, Bone, Lymph node, Endothelial, Lung, Breast, Skin, Brain, Spinal cord, Bone marrow, Colon, Pituitary, Liver, Monocytes, T cells, Kidney, Placenta, Testis, Testes, Cervix, Myeloid, Neutrophil

Animal Models for Prostate Adenocarcinoma or affiliated genes

About this section

Publications for Prostate Adenocarcinoma

About this section

Articles related to Prostate Adenocarcinoma:

(show top 50)    (show all 718)
idTitleAuthorsYear
1
The potential of neurotensin secreted from neuroendocrine tumor cells to promote gelsolin-mediated invasiveness of prostate adenocarcinoma cells. (25581609)
2015
2
Penile nodule with inguinal lymphadenopathy: Prostatic adenocarcinoma masquerading as penile cancer. (23671367)
2013
3
Lymphangitic pulmonary metastases in castrate-resistant prostate adenocarcinoma. (22924050)
2012
4
Metastatic prostate adenocarcinoma presenting central diabetes insipidus. (22474455)
2012
5
PSA nadir of <0.5 ng/mL following brachytherapy for early-stage prostate adenocarcinoma is associated with freedom from prostate-specific antigen failure. (21985944)
2012
6
Low dose of ketoconazole in patients with prostate adenocarcinoma resistant to pharmacological castration. (21929520)
2011
7
Multifaceted preventive effects of single agent quercetin on a human prostate adenocarcinoma cell line (PC-3): implications for nutritional transcriptomics and multi-target therapy. (20596804)
2011
8
Metastatic prostate adenocarcinoma invading an atypical meningioma. (22000836)
2011
9
Prostate adenocarcinoma with orbital metastasis in an HIV+ man. (21504657)
2011
10
Toxicity report of once weekly radiation therapy for low-risk prostate adenocarcinoma: preliminary results of a phase I/II trial. (21906281)
2011
11
Efficacy and safety of docetaxel plus prednisolone chemotherapy for metastatic hormone-refractory prostate adenocarcinoma: single institutional study in Korea. (20369046)
2010
12
Distal seminal vesicle invasion by prostate adenocarcinoma does not occur in isolation of proximal seminal vesicle invasion or lymphovascular infiltration. (20438404)
2010
13
Histological patterns and associated PSA levels for prostatic adenocarcinoma following brachytherapy. (19646822)
2009
14
Regulation and expression of human CYP7B1 in prostate: overexpression of CYP7B1 during progression of prostatic adenocarcinoma. (17639508)
2007
15
Histopathological changes induced by therapies in the benign prostate and prostate adenocarcinoma. (17128417)
2007
16
Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features. (17139617)
2007
17
Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma. (17606331)
2007
18
Single small focus of prostate adenocarcinoma (< or = 1 mm and too small for grading) and clinical significant disease after radical prostatectomy. (16929604)
2006
19
Comparative in vitro and in vivo evaluation of two 64Cu-labeled bombesin analogs in a mouse model of human prostate adenocarcinoma. (16631086)
2006
20
Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models. (16357178)
2005
21
15-lipoxygenase metabolites of gamma-linolenic acid/eicosapentaenoic acid suppress growth and arachidonic acid metabolism in human prostatic adenocarcinoma cells: possible implications of dietary fatty acids. (15850718)
2005
22
Number and location of nucleoli and presence of apoptotic bodies in diagnostically challenging cases of prostate adenocarcinoma on needle biopsy. (16260270)
2005
23
A decrease in 1H nuclear magnetic resonance spectroscopically determined citrate in human seminal fluid accompanies the development of prostate adenocarcinoma. (15643195)
2005
24
Clinical understaging in patients with prostate adenocarcinoma submitted to radical prostatectomy: predictive value of serum chromogranin A. (14968443)
2004
25
microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts. (15299066)
2004
26
Characterization of initiation of angiogenesis in early stages of prostate adenocarcinoma development and progression in a transgenic murine model. (15596214)
2004
27
Cystic solitary intracerebral metastasis from prostate adenocarcinoma. (11326565)
2001
28
PSA kinetics after external beam radiotherapy alone or combined with an iridium brachytherapy boost to deliver 85 grays to prostatic adenocarcinoma. (11233840)
2001
29
Prostatic adenocarcinoma with neuroendocrine differentiation of the small cell type]. (11474882)
2001
30
Hypokalemia, metabolic alkalosis, and hypertension: Cushing's syndrome in a patient with metastatic prostate adenocarcinoma. (11273885)
2001
31
Comparison of positivity frequency of bcl-2 expression in prostate adenocarcinoma with low and high Gleason score. (11500787)
2001
32
Prostatic adenocarcinoma metastatic to the breasts: report of a case with diagnosis by fine needle aspiration biopsy. (10754179)
2000
33
Treatment of metastatic hormone-refractory prostate adenocarcinoma (MatLyLu) in Copenhagen rats with micro-osmotic interleukin-2 pumps. (11205294)
2000
34
Effects of N-(4-hydroxyphenyl) retinamide on urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in prostate adenocarcinoma cell lines. (10824459)
2000
35
Whole genome amplification and molecular genetic analysis of DNA from paraffin-embedded prostate adenocarcinoma tumor tissue. (10492247)
1999
36
Prostate adenocarcinoma presenting as a solitary choroidal metastasis. (9740957)
1998
37
Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases. (9763084)
1998
38
Apoptosis in prostatic adenocarcinomas; a study of relationship to Ki-67 and Bcl-2 protein expression. (9615774)
1998
39
Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system. (9426741)
1997
40
Case report. Two contrasting radiological presentations of prostatic adenocarcinoma in the jaws. (9161183)
1996
41
Normal range prostate-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinoma. (7542822)
1995
42
DNA ploidy, serum prostate specific antigen, histological grade and immunohistochemistry as predictive parameters of lymph node metastases in T1-T3/M0 prostatic adenocarcinoma. (7531589)
1995
43
Ploidy status correlates with outcome in stage B prostate adenocarcinoma. (8173528)
1994
44
Natural course of clinically localized prostate adenocarcinoma in men less than 70 years old. (2056609)
1991
45
Cutaneous metastasis originating from prostate adenocarcinoma. (2066195)
1991
46
Chylous ascites as a presenting sign of prostatic adenocarcinoma. (2077299)
1990
47
The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study. (1699237)
1990
48
The relationship of natural killer cells to metastasis of a transplantable prostate adenocarcinoma. (2417216)
1985
49
Unusual metastatic patterns of prostate adenocarcinoma. (6195357)
1983
50
Metastasis of rat prostate adenocarcinoma cells. (6798581)
1981

Variations for Prostate Adenocarcinoma

About this section

Expression for genes affiliated with Prostate Adenocarcinoma

About this section
Search GEO for disease gene expression data for Prostate Adenocarcinoma.

Pathways for genes affiliated with Prostate Adenocarcinoma

About this section

Pathways related to Prostate Adenocarcinoma according to GeneCards Suite gene sharing:

idSuper pathways (with members indented)ScoreTop Affiliating Genes
1
Show member pathways
9.6ALOX15, ALOX15B
2
Show member pathways
aspirin triggered resolvin E biosynthesis36
9.6ALOX15, ALOX15B

Compounds for genes affiliated with Prostate Adenocarcinoma

About this section
Sources:
24HMDB, 43Novoseek
See all sources

Compounds related to Prostate Adenocarcinoma according to GeneCards Suite gene sharing:

idCompoundScoreTop Affiliating Genes
115(S)-HPETE249.6ALOX15, ALOX15B
213-L-Hydroperoxylinoleic acid249.5ALOX15, ALOX15B
315-hydroxyeicosatetraenoic acid439.3ALOX15, ALOX15B

GO Terms for genes affiliated with Prostate Adenocarcinoma

About this section

Cellular components related to Prostate Adenocarcinoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1membraneGO:00160209.0ALOX15, ALOX15B, FOLH1, DCXR

Biological processes related to Prostate Adenocarcinoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1arachidonic acid metabolic processGO:00193699.6ALOX15, ALOX15B
2hepoxilin biosynthetic processGO:00511229.5ALOX15, ALOX15B
3lipoxygenase pathwayGO:00193729.3ALOX15, ALOX15B

Molecular functions related to Prostate Adenocarcinoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1arachidonate 15-lipoxygenase activityGO:00504739.6ALOX15, ALOX15B

Products for genes affiliated with Prostate Adenocarcinoma

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies
  • Proteins
  • Kits and Assays

Sources for Prostate Adenocarcinoma

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
33MeSH
34MESH via Orphanet
35MGI
38NCIt
39NDF-RT
42NINDS
43Novoseek
45OMIM
46OMIM via Orphanet
50PubMed
51QIAGEN
56SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet